Value-Based Retail Sets Sail: Novartis China and Shanghai Pharma Holdings Launch Strategic Partnership

Nov 04, 2024 18:08 CST Updated 18:08

Novartis China

Innovative Drug Developer

Shanghai Pharma

Modern Pharmaceutical Supply Chain Service Provider

October 31, 2024Novartis China and Shanghai Pharmaceutical Co., Ltd. (referred to as: Shanghai Pharma) held a strategic cooperation launch meeting. "Value Retail, Setting Sail"Both parties will deepen cooperation in enhancing the professional services of retail pharmacies based on their shared goals and vision in the pharmaceutical retail sector, leveraging their respective resources and strengths to meet patients' needs for health products and professional pharmaceutical care. This collaboration aims to maximize synergies and provide Chinese patients with more healthcare choices.

Wang Junxing, Head of Retail at Novartis China, and Li Zhigang, Director of Retail Business at Shanghai Pharmaceutical Co., Ltd. and Chairman of Shanghai Pharmaceutical Cloud Health, as representatives of both parties, reached a high level of consensus on the concept of focusing on patients, empowering retail pharmacies, comprehensively building professional retail value, and jointly benefiting patients. Hou Yanqing, Head of National Key Customers for Novartis Retail, Xu Ye, General Manager of the Retail Business Development Center at Shanghai Pharmaceutical Co., Ltd. and General Manager of Shanghai Huashi Pharmacy, and other guests present, jointly witnessed this important moment.

Wang Junxing, Head of Novartis Retail

Wang Junxing, head of Novartis' retail division, stated that Novartis has been deeply engaged in the Chinese market for many years and maintains a long-term close partnership with Shanghai Pharmaceutical Co., Ltd. Novartis firmly believes that, as a leading enterprise in the pharmaceuticals industry, Shanghai Pharmaceutical Co., Ltd. will drive the systematic development of China's pharmaceutical retail industry and create a new model for pharmaceutical retail cooperation.

Proposed by Novartis"Value Retail"The concept aims to address the key pain points in patients' disease management needs, advocating for the establishment of a professional patient management system. By creating value-driven pharmacies and enhancing pharmacists' professional capabilities, it seeks to achieve specialized patient management and collectively transition the role of pharmacies into professional health service providers. It is hoped that both parties will continue to maximize the value of retail pharmacies, collaborate to sustain professional health services, and ultimately benefit patients' health.

Shanghai Pharmaceutical Co.,Ltd. Retail Business Director,Chairman of Shanghai Pharmaceutical Cloud Health, Li Zhigang

Li Zhigang, Director of Retail Business at Shanghai Pharmaceutical Co., Ltd. and Chairman of SPH Cloud Health, stated that Shanghai Pharmaceutical places high importance on the pharmaceutical retail sector, continuously advancing service innovation and retail integration. To date, more than 900 pharmacies under Shanghai Pharmaceutical offer popular products from various fields of Novartis China.

Among them, SPD Cloud Health, a subsidiary of Shanghai Pharmaceutical Co., Ltd., as China's leading innovative drug full-cycle service platform, has been operating with dedication for 9 years."Yi Yao Pharmacy"Already ownedExtensive nationwide resource network, a solid system operation management system and high-level professional pharmaceutical services capabilities.At the same time, located in Xuhui District, Shanghai"Yi Yao·Comprehensive Flagship Entity"As a hub for patient health management and a benchmark for a new model of professional pharmaceutical services, it will drive more stores to focus on professional services as the key to long-term development, fully highlighting the value of professional pharmacies.

Value Retail Sets Sail

In the future, Shanghai Pharmaceutical Co., Ltd. and Shanghai Pharma Cloud Health will continue to expand the scope of pharmaceutical services, deeply explore the depth and breadth of various innovative drug services, enhance the coverage and accessibility of more innovative products from Novartis, and accelerate the provision of higher-standard, more professional full-cycle services for innovative drugs. This will allow globally leading innovative medicines to benefit more patients and move towards the beautiful vision of "value retail."

Company Introduction

Since its establishment in 2015 by Shanghai Pharmaceutical Co., Ltd., Shanghai Pharma Cloud Health has been operating under the broader context of Healthy China, consistently adhering to a "patient-centered" approach. It actively participates in advancing the commercialization of innovative drugs, improving patients' access to medications, services, and payment options. It also supports the reform of the medical and health system, pioneering a specialized pharmacy model in China that separates pharmaceuticals from medical practice.

The company has created a professional service brand for prescription drugs centered on the core concept of "For novel specialty medicines, choose Yi Yao." Currently, "Yi Yao Pharmacy," a nationwide integrated specialty pharmacy, has over 200 branches, covering 66 cities across 25 provinces in China. It provides more than 300 foreign MNCs and domestic innovative pharmaceutical companies with comprehensive supply chain services, precision marketing, charitable assistance, patient education, citywide惠民insurance, and other innovative payment solutions, becoming the preferred channel for globally advanced innovative therapies to enter the Chinese market.

Shanghai Pharmaceutical Cloud Health continues to deepen its digital business and upgrade its internet platform, providing professional services such as digital marketing, patient services, innovative payment solutions, and internet hospital operations to governments, medical institutions, R&D and pharmaceutical companies, as well as payers. By building an internet hospital platform and a specialized disease diagnosis and treatment system, it offers patients an integrated healthcare solution that combines "medical care, pharmaceuticals, insurance, and management."